| |
| |
|
| Insider
Information: |
Damelio Frank A |
| Relationship: |
Director |
| City: |
Murray Hill |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
582,165 |
|
|
Indirect Shares
|
38,024 |
|
|
| Direct
Value |
$16,971,712 |
|
|
|
Indirect Value
|
$6,610,527 |
|
|
| Total
Shares |
620,189 |
|
|
| Total
Value |
$23,582,239 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Humana Inc |
HUM |
Director |
2016-09-21 |
0 |
2016-09-21 |
20,634 |
Premium* |
|
|
Pfizer Inc |
PFE |
Executive Vice President |
2022-02-26 |
555,941 |
2019-02-04 |
0 |
Premium* |
|
|
Zoetis Inc. |
ZTS |
Director |
2021-02-13 |
14,808 |
2013-02-06 |
0 |
Premium* |
|
|
Hewlett Packard Enterprise Co |
HPE |
Director |
2024-04-10 |
3,444 |
2024-04-10 |
17,390 |
Premium* |
|
|
Catalent, Inc. |
CTLT |
Director |
2023-10-27 |
7,972 |
2023-08-28 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HPE |
Hewlett Packard Enterpris... |
Director |
– • – |
2024-04-10 |
4 |
OE |
$0.00 |
$0 |
I/I |
17,390 |
17,390 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2023-10-27 |
4 |
A |
$0.00 |
$0 |
D/D |
6,993 |
7,972 |
0 |
- |
|
| CTLT |
Catalent, Inc. |
Director |
– • – |
2023-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
979 |
979 |
0 |
- |
|
| HPE |
Hewlett Packard Enterpris... |
Director |
– • – |
2023-04-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,444 |
3,444 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2022-02-26 |
4 |
D |
$47.72 |
$4,657,943 |
D/D |
(93,977) |
555,941 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2022-02-26 |
4 |
OE |
$25.60 |
$3,255,296 |
D/D |
127,160 |
649,918 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2022-02-23 |
4 |
OE |
$27.34 |
$4,204,591 |
D/D |
153,789 |
636,977 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2022-02-23 |
4 |
D |
$46.87 |
$5,689,134 |
D/D |
(114,219) |
522,758 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2021-02-27 |
4 |
D |
$33.49 |
$4,272,636 |
D/D |
(124,253) |
483,188 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2021-02-27 |
4 |
OE |
$22.35 |
$3,414,745 |
D/D |
152,785 |
607,441 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2021-02-25 |
4 |
OE |
$22.89 |
$3,738,715 |
D/D |
163,334 |
588,584 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2021-02-25 |
4 |
D |
$33.82 |
$4,628,810 |
D/D |
(133,928) |
454,656 |
0 |
- |
|
| ZTS |
Zoetis Inc. |
Director |
– • – |
2021-02-13 |
4 |
D |
$166.71 |
$147,872 |
D/D |
(887) |
14,808 |
0 |
- |
|
| ZTS |
Zoetis Inc. |
Director |
– • – |
2021-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,779 |
15,695 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-28 |
4 |
OE |
$27.37 |
$4,753,485 |
D/D |
173,675 |
556,084 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-28 |
4 |
D |
$33.42 |
$4,644,327 |
D/D |
(130,834) |
425,250 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-26 |
4 |
D |
$34.72 |
$5,281,064 |
D/D |
(145,477) |
382,409 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-26 |
4 |
A |
$0.00 |
$0 |
D/D |
45,566 |
527,886 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2020-02-26 |
4 |
OE |
$34.59 |
$5,013,060 |
D/D |
144,928 |
482,320 |
0 |
- |
|
| ZTS |
Zoetis Inc. |
Director |
– • – |
2020-02-14 |
4 |
D |
$144.17 |
$170,409 |
D/D |
(1,182) |
12,916 |
0 |
- |
|
| ZTS |
Zoetis Inc. |
Director |
– • – |
2020-02-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,704 |
14,098 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-07-02 |
4 |
AS |
$44.00 |
$6,753,385 |
D/D |
(153,184) |
337,392 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-27 |
4 |
D |
$42.31 |
$8,249,365 |
D/D |
(193,784) |
490,576 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
96,183 |
684,360 |
0 |
- |
|
| PFE |
Pfizer Inc |
Executive Vice President |
• • – |
2019-02-27 |
4 |
OE |
$32.23 |
$5,873,821 |
D/D |
182,247 |
588,177 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
